Parkinson's disease
Conditions
Sponsors
Takeda Pharmaceutical Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The participant is capable of operating each device used in this study, and understanding and complying with protocol requirements, in the opinion of the investigator. 2. The participant signs and dates a written, informed consent form prior to the initiation of any study procedures. 3. The participant has been diagnosed with Parkinson's disease on the basis of standardized diagnostic criteria. 4. The participant has some difficulty in visiting the outpatient clinic, and it is preferable to conduct online examination, online instruction on the use of drugs, and delivering drugs as part of regular care, in the opinion of the investigator. 5. The participant is a resident of Kanagawa Prefecture. 6. The participant is aged 20 years or older at the time of informed consent. 7. The participant is capable of visiting the outpatient clinic during the evaluation period.
Exclusion criteria
Exclusion criteria: 1. The participant has metal allergy. 2. The participant has cognitive impairment that, in the opinion of the investigator, would interfere with the ability to report on symptoms and function. 3. The participant has unstable Parkinson's disease and co-morbidities. 4. The participant is judged by the investigator as being ineligible for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| other Patient satisfaction with examination and instruction on the use of drugs (Client Satisfaction Questionnaire 8 [CSQ-8]) Time Frame: Week 0, 4 and 16 | — |
Secondary
| Measure | Time frame |
|---|---|
| other Satisfactions and issues with the platform (using questionnaire filled by patients, caregivers, physicians, medical office work divisions of the medical institutions, and pharmacists) Time Frame: Week 16 | — |
Countries
Japan
Outcome results
None listed